JOINT FILING AGREEMENT
Exhibit
99.1
The
undersigned hereby agree that the statement on Schedule 13D with respect to the
shares of common stock of NovaDel Pharma Inc. is, and any amendment thereto
signed by each of the undersigned shall be, filed on behalf of each of the
undersigned pursuant to and in accordance with the provisions of Rule
13d-1(k) promulgated under the Securities Exchange Act of 1934, as
amended. The undersigned hereby further agree that this Joint Filing
Agreement be included as an exhibit to such statement and any such
amendment. This Joint Filing Agreement may be executed in any number
of counterparts, all of which taken together shall constitute one and the same
instrument.
|
Dated: December
23, 2008
|
|||
| /s/ Xxxxxxxx XxXxxxxxx | |||
|
Xxxxxxxx
XxXxxxxxx, as a member of ProQuest Associates III LLC and on behalf of
ProQuest Investments III, L.P., and as a member of ProQuest Associates II
LLC and on behalf of ProQuest Investments II, L.P. and ProQuest
Investments II Advisors Fund, L.P.
|
|||
|
*
|
|||
|
Xxx
Xxxxxx, individually
|
|||
|
*
|
|||
|
Xxxxx
Xxxxxxxxx,
individually
|
|
*By:
|
/s/ Xxxxxxxx XxXxxxxxx | |
|
Xxxxxxxx
XxXxxxxxx, Attorney-in-Fact
Power
of attorney filed as an exhibit hereto
|